Synthesis and antitumour activity of 4-hydroxy-2-pyridone derivatives

被引:93
作者
Cocco, MT [1 ]
Congiu, C [1 ]
Onnis, V [1 ]
机构
[1] Univ Cagliari, Dipartimento Tossicol, I-09124 Cagliari, Italy
关键词
4-hydroxy-2-pyridone derivatives; bis(pyridyl)methanes; antitumour activity;
D O I
10.1016/S0223-5234(00)00149-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-hydroxy-2-pyridone derivatives 2 were prepared by reaction of 3-amino-3-dialkylaminopropenoates with bis(2,4,6-trichlorophenyl)malonate. These compounds were further reacted with a set of aldehydes to give bis(pyridyl)methanes 3 and 4. The newly synthesized compounds 2, 3 and 4 were evaluated in vitro as antitumour agents against 60 human tumour cell lines. Some derivatives exhibit tumour growth inhibition activity. In particular, derivative 4g, the most active of the series, possesses significant activity on all cell lines at concentrations ranging from 1 x 10(-6) to 1 x 10(-5) M. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 13 条
[1]  
Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1
[2]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[3]  
COCCO MT, 1988, SCI, V43, P103
[4]   ANTIMYCOBACTERIAL 4-HYDROXY-3-PHENYLPYRIDIN-2(1H)-ONES [J].
DANNHARDT, G ;
MEINDL, W ;
SCHOBER, BD ;
KAPPE, T .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (06) :599-604
[5]   A NEW SERIES OF PYRIDINONE DERIVATIVES AS POTENT NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS [J].
DOLLE, V ;
FAN, E ;
NGUYEN, CH ;
AUBERTIN, AM ;
KIRN, A ;
ANDREOLA, ML ;
JAMIESON, G ;
TARRAGOLITVAK, L ;
BISAGNI, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (23) :4679-4686
[6]  
GREVER MR, 1992, SEMIN ONCOL, V19, P622
[7]   ACTIVE MALONATES AS SYNTHONS FOR HETEROCYCLES - A METHOD FOR THE PRODUCTION OF 4-HYDROXY-2(1H)-PYRIDONES [J].
KAPPE, T ;
AJILI, S ;
STADLBAUER, W .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1988, 25 (02) :463-468
[8]  
KAPPE T, 1995, ENCY REAGENTS ORGANI, V1, P557
[9]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766
[10]  
Plowman J, 1997, ANTICANCER DRUG DEV, P101